A focus on overall wellness: new hope for the seriously ill. Pharmaceutical-academic partnership moves well beyond symptom reduction.
Kosseff
Christopher
C
University of Medicine and Dentistry of New Jersey-University Behavioral HealthCare (UMDNJ-UBHC), USA.
Vreeland
Betty
B
D000046:Academic Medical Centers; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001524:Behavioral Medicine / Q000193:education / Q000379:methods*; D015897:Comorbidity; D004345:Drug Industry; D015438:Health Behavior; D006293:Health Promotion / Q000379:methods*; D006694:Holistic Health; D006801:Humans; D007857:Leadership; D001523:Mental Disorders / Q000188:drug therapy / Q000628:therapy*; D009515:New Jersey; D010348:Patient Care Team; D016730:Program Development; D012309:Risk-Taking
D014150:Antipsychotic Agents